Target intelligence / Profile preview

Mitochondrial peptide deformylase (PDF)

Target
PDF
Molecular classification
Enzyme, Metalloprotease, Deformylase
01

Overview

Mitochondrial peptide deformylase (PDF) is a nuclear-encoded metalloenzyme essential for the maturation of proteins synthesized within the mitochondria (UniProt Q9HBH1; NCBI Gene ID: 64146). In human mitochondria, as in bacteria, protein translation initiates with N-formylmethionine; PDF catalyzes the removal of this N-formyl group from nascent polypeptides, a step that is a prerequisite for subsequent N-terminal methionine excision (PMID: 15103325). This process is vital for the stability and assembly of the 13 proteins encoded by mitochondrial DNA, all of which are core subunits of the oxidative phosphorylation (OXPHOS) machinery (PMID: 20837555). Because many cancer cells rely heavily on mitochondrial biogenesis and OXPHOS to sustain rapid growth, PDF is often overexpressed in various malignancies, making it a promising target for anti-cancer therapy (PMID: 36812345). Inhibitors like the natural product actinonin can trigger mitochondrial proteotoxic stress and apoptosis in cancer cells by blocking this maturation process (PMID: 20837555). However, the high structural similarity between human mitochondrial PDF and bacterial PDF presents a therapeutic challenge, as antibacterial drugs targeting this enzyme must be carefully designed to avoid off-target mitochondrial toxicity in human patients (PMID: 22432445).

Other names
Peptide deformylase, mitochondrialPolypeptide deformylasePDFMPDFL1
02

Mechanism of action

Inhibition of the removal of the N-formyl group from the N-terminal methionine of nascent mitochondrial proteins, leading to impaired protein maturation, proteotoxic stress, and mitochondrial dysfunction.

03

Biological functions

Protein maturationN-terminal methionine excisionMitochondrial protein synthesisMitochondrial biogenesisOxidative phosphorylation regulation
04

Disease associations

CancerInfectionMitochondrial diseases
05

Safety considerations

Mitochondrial toxicity in healthy tissuesOff-target effects from antibacterial PDF inhibitorsPotential for peripheral neuropathyImpairment of oxidative phosphorylation
06

Interacting drugs

Actinonin

3 more in the full profile.

07

Biomarkers

N-formylmethionine levelsMitochondrial membrane potentialOXPHOS protein expression levelsCellular ATP/ADP ratio

Beyond the preview

Go deeper on Mitochondrial peptide deformylase (PDF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial peptide deformylase (PDF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call